Literature DB >> 20550739

Should we stop using tricyclic antidepressants in pregnancy?

C M Pariante, G Seneviratne, L Howard.   

Abstract

A new Swedish study by Reis & Källén describes approximately 15,000 women (and their babies) that, between 1995 and 2007, reported the use of antidepressants, or were prescribed such drugs, during pregnancy. In this study, pregnancy and teratogenic outcomes after exposure to tricyclic antidepressants are, for most measures, equal or worse than after exposure to selective serotonin reuptake inhibitors or other antidepressants. Based on this and on a review of the few other studies available (admittedly, a relatively small number of women on which conclusions can be based), the authors of this Editorial challenge the 'perinatal myth' that tricyclics are the safest choice in pregnancy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20550739     DOI: 10.1017/S003329171000022X

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  2 in total

1.  The inhibition characteristics of human placental glutathione S-transferase-π by tricyclic antidepressants: amitriptyline and clomipramine.

Authors:  Ozlem Dalmizrak; Gulnihal Kulaksiz-Erkmen; Nazmi Ozer
Journal:  Mol Cell Biochem       Date:  2011-05-13       Impact factor: 3.396

Review 2.  Antenatal depression and children's developmental outcomes: potential mechanisms and treatment options.

Authors:  Cerith S Waters; Dale F Hay; Jessica R Simmonds; Stephanie H M van Goozen
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-07-19       Impact factor: 4.785

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.